Funder: FDA

Link: https://beta.sam.gov/opp/e88eb149e93c4a92aa980730b07dd7c4/view

About: “The purpose of this sources sought Request for Information (RFI) is to collect data on technical business services, capabilities, and informational input from the marketplace for project planning purposes regarding the availability of existing or potential solutions to optimize the effectiveness of regulatory oversight for The Food and Drug Administration (FDA) Center for Drug Evaluation Research (CDER), Office of Business Informatics (OBI). The FDA OBI is seeking information from commercial industry on capabilities related to applying health and life science innovation, digital health, artificial intelligence, advanced analytics, statistical process control, application pattern recognition, and risk categorization.”

Funder: NIH

Link: https://nexus.od.nih.gov/all/2020/04/13/covid-19-funding-and-funding-opportunities/

About: “As you can imagine, NIH is devoting significant resources to COVID-19. In addition to dedicating regularly appropriated funds, to date NIH has received emergency funding for COVID-19-related activities in two supplemental bills (available from the NIH Office of Budget website), that together provide:

• $1.532 billion for NIAID

• $103.4 million for NHLBI

• $60 million for NIBIB

• $36 million for NCATS

• $30 million for the NIH Office of Director

• $10 million for NIEHS

• $10 million for NLM

  To get funding as quickly as possible to the research community, we are using Urgent and Emergency competing revisions and administrative supplements to existing grant awards. This approach allows us to leverage resident expertise, getting additional funding to those researchers who are already working with other organisms, models, or tools so that they can quickly shift focus to the novel coronavirus. These Urgent and Emergency competitive revision Funding Opportunity Announcements (FOAs) allow NIH to fund applications quickly, often in under three months, sometimes much quicker than that, because evaluation for scientific and technical merit is done by an internal review panel convened by staff of the NIH awarding institute or center rather than by our traditional peer review process.”